The Motley Fool··Prosper Junior BakinyVertex Pharmaceuticals Outpaces Centessa With Established Revenue and Advanced Pipeline
Vertex Pharmaceuticals outperforms Centessa with profitable cystic fibrosis revenue, successful product launches, and advanced pipeline, offering lower-risk investment profile versus pre-revenue competitor.
VRTXCNTAbiotechclinical trials